A Randomized, Open-label, Active Control Trial to Evaluate the Effect of LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Losartan (Primary) ; Atenolol; Propranolol
- Indications Aortic disorders; Marfan's syndrome
- Focus Therapeutic Use
- 12 Jan 2013 Primary endpoint 'ECG-changes' has been met.
- 12 Jan 2013 Status changed from recruiting to completed.
- 18 Feb 2011 New trial record